| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | Jan 31, 2024 | Tourmaline Bio, Inc. | Director | Buy | 100.0 | +100,000 | 15.57% | ✗ | $3.3M |
| Jan 27, 2023 | Apr 11, 2023 | Jasper Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +2,666,666 | 45.56% | ✗ | $4M |